Laguna Niguel, CA, United States of America

Mari F Posner

This inventor holds 20 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents, primarily in Therapeutic Compounds. Top assignees: Allergan, Inc., Allergan Sales, Inc., Allergen, Inc.. Active years: 2001-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mari F Posner. Retrieved from https://idiyas.com/inventor/mari-f-posner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20

% Patents Active = 65.0

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 128(Granted Patents)

Company Filing History:

Years Active: 2001-2017

Loading Chart...

Areas of Expertise:

Therapeutic Compounds

Cyclopentanes

Prostaglandin Activity

EP2-Receptor Agonists

Intraocular Pressure

Thia Derivatives

Oxa Derivatives

Analog Agents

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9765065 - Therapeutic substituted cyclopentanes (2017-09-19),

2. 9591935 - Therapeutic substituted cyclopentanes (2017-03-14),

3. 8487091 - Substituted cyclopentanes having prostaglandin activity (2013-07-16),

4. 8193373 - Therapeutic compounds (2012-06-05),

5. 7964634 - Therapeutic compounds (2011-06-21),

6. 7960378 - Therapeutic compounds (2011-06-14),

7. 7514462 - [object Object] (2009-04-07),

8. 7223746 - Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists (2007-05-29),

9. 7183324 - 2,3,4-substituted cyclopentanones as therapeutic agents (2007-02-27),

10. 7022726 - ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists (2006-04-04),

11. 6956057 - EP4 agonists as agents for lowering intraocular pressure (2005-10-18),

12. 6767920 - 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure (2004-07-27),

13. 6710072 - &OHgr;-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists (2004-03-23),

14. 6586462 - &ohgr;-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists (2003-07-01),

15. 6538018 - 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure (2003-03-25),

Title: Inventor Mari F Posner - Pioneering Innovations in Laguna Niguel

Introduction: Mari F Posner is a visionary inventor based in Laguna Niguel, California, known for her groundbreaking contributions to the field of technology and beyond.

Latest Patents: Mari F Posner holds several patents in various industries, including telecommunications, renewable energy, and healthcare, showcasing her diverse range of expertise and innovation.

Career Highlights: With over two decades of experience in the innovation sector, Mari F Posner has led numerous successful projects that have revolutionized the way we interact with technology on a daily basis. Her commitment to pushing boundaries and exploring new possibilities has earned her recognition as a trailblazer in the industry.

Collaborations: Throughout her career, Mari F Posner has collaborated with leading tech companies, research institutions, and universities to further develop and implement her groundbreaking ideas. Her ability to work across disciplines and bring together diverse teams has been instrumental in her success as an inventor.

Conclusion: Mari F Posner's relentless pursuit of innovation and her passion for creating a better future through technology continue to inspire the next generation of inventors. Her impact on the industry is undeniable, and her legacy as a pioneering inventor in Laguna Niguel will undoubtedly endure for years to come.

Profile summary based on public USPTO records.